UniProt ID | H2A2A_HUMAN | |
---|---|---|
UniProt AC | Q6FI13 | |
Protein Name | Histone H2A type 2-A | |
Gene Name | HIST2H2AA3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 130 | |
Subcellular Localization | Nucleus. Chromosome. | |
Protein Description | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.. | |
Protein Sequence | MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYMAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKTESHHKAKGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSGRGKQGG ------CCCCCCCCH | 36.88 | 16319397 | |
2 | Acetylation | ------MSGRGKQGG ------CCCCCCCCH | 36.88 | 15823041 | |
4 | Citrullination | ----MSGRGKQGGKA ----CCCCCCCCHHH | 41.66 | - | |
4 | Methylation | ----MSGRGKQGGKA ----CCCCCCCCHHH | 41.66 | - | |
4 | Citrullination | ----MSGRGKQGGKA ----CCCCCCCCHHH | 41.66 | 15823041 | |
6 | Methylation | --MSGRGKQGGKARA --CCCCCCCCHHHHH | 44.39 | 19608861 | |
6 | Acetylation | --MSGRGKQGGKARA --CCCCCCCCHHHHH | 44.39 | 16457589 | |
6 | Other | --MSGRGKQGGKARA --CCCCCCCCHHHHH | 44.39 | 24681537 | |
10 | Acetylation | GRGKQGGKARAKAKS CCCCCCHHHHHHHHH | 41.34 | 19608861 | |
10 | Lactoylation | GRGKQGGKARAKAKS CCCCCCHHHHHHHHH | 41.34 | - | |
10 | Other | GRGKQGGKARAKAKS CCCCCCHHHHHHHHH | 41.34 | 27105115 | |
10 | Succinylation | GRGKQGGKARAKAKS CCCCCCHHHHHHHHH | 41.34 | 19608861 | |
14 | Acetylation | QGGKARAKAKSRSSR CCHHHHHHHHHHHHC | 51.28 | - | |
14 | Ubiquitination | QGGKARAKAKSRSSR CCHHHHHHHHHHHHC | 51.28 | 22980979 | |
14 | Other | QGGKARAKAKSRSSR CCHHHHHHHHHHHHC | 51.28 | 27105115 | |
16 | Ubiquitination | GKARAKAKSRSSRAG HHHHHHHHHHHHCCC | 45.77 | 22980979 | |
17 | Phosphorylation | KARAKAKSRSSRAGL HHHHHHHHHHHCCCC | 42.10 | 23882029 | |
19 | Phosphorylation | RAKAKSRSSRAGLQF HHHHHHHHHCCCCCC | 31.13 | 30622161 | |
20 | Phosphorylation | AKAKSRSSRAGLQFP HHHHHHHHCCCCCCC | 25.66 | 27966365 | |
21 | Methylation | KAKSRSSRAGLQFPV HHHHHHHCCCCCCCH | 33.64 | - | |
30 | Methylation | GLQFPVGRVHRLLRK CCCCCHHHHHHHHHC | 22.69 | - | |
37 | N6-crotonyl-L-lysine | RVHRLLRKGNYAERV HHHHHHHCCCHHHHC | 52.02 | - | |
37 | Crotonylation | RVHRLLRKGNYAERV HHHHHHHCCCHHHHC | 52.02 | 21925322 | |
37 | Other | RVHRLLRKGNYAERV HHHHHHHCCCHHHHC | 52.02 | 27105115 | |
37 | Ubiquitination | RVHRLLRKGNYAERV HHHHHHHCCCHHHHC | 52.02 | 27667366 | |
40 | Phosphorylation | RLLRKGNYAERVGAG HHHHCCCHHHHCCCC | 20.64 | 28152594 | |
51 | Phosphorylation | VGAGAPVYMAAVLEY CCCCHHHHHHHHHHH | 4.68 | - | |
58 | Phosphorylation | YMAAVLEYLTAEILE HHHHHHHHHHHHHHH | 12.75 | - | |
72 | Dimethylation | ELAGNAARDNKKTRI HHCCHHHHCCCCCCE | 45.70 | - | |
72 | Methylation | ELAGNAARDNKKTRI HHCCHHHHCCCCCCE | 45.70 | - | |
75 | Other | GNAARDNKKTRIIPR CHHHHCCCCCCEEHH | 60.87 | 24681537 | |
76 | Other | NAARDNKKTRIIPRH HHHHCCCCCCEEHHH | 49.65 | 24681537 | |
77 | Phosphorylation | AARDNKKTRIIPRHL HHHCCCCCCEEHHHH | 28.80 | 23882029 | |
82 | Methylation | KKTRIIPRHLQLAIR CCCCEEHHHHHHHHC | 32.51 | - | |
89 | Methylation | RHLQLAIRNDEELNK HHHHHHHCCHHHHHH | 38.65 | - | |
96 | Other | RNDEELNKLLGKVTI CCHHHHHHHHCCEEE | 58.68 | 27105115 | |
96 | Glutarylation | RNDEELNKLLGKVTI CCHHHHHHHHCCEEE | 58.68 | 31542297 | |
96 | Acetylation | RNDEELNKLLGKVTI CCHHHHHHHHCCEEE | 58.68 | 19608861 | |
96 | Ubiquitination | RNDEELNKLLGKVTI CCHHHHHHHHCCEEE | 58.68 | 27667366 | |
96 | Neddylation | RNDEELNKLLGKVTI CCHHHHHHHHCCEEE | 58.68 | 32015554 | |
96 | Succinylation | RNDEELNKLLGKVTI CCHHHHHHHHCCEEE | 58.68 | 19608861 | |
100 | Acetylation | ELNKLLGKVTIAQGG HHHHHHCCEEECCCC | 35.85 | 158613 | |
100 | Ubiquitination | ELNKLLGKVTIAQGG HHHHHHCCEEECCCC | 35.85 | 23000965 | |
100 | Glutarylation | ELNKLLGKVTIAQGG HHHHHHCCEEECCCC | 35.85 | 31542297 | |
102 | Phosphorylation | NKLLGKVTIAQGGVL HHHHCCEEECCCCCC | 17.68 | 24732914 | |
105 | Methylation | LGKVTIAQGGVLPNI HCCEEECCCCCCCCE | 45.37 | 24352239 | |
119 | Neddylation | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 32015554 | |
119 | Acetylation | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 158653 | |
119 | N6-crotonyl-L-lysine | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | - | |
119 | Ubiquitination | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 25015289 | |
119 | Glutarylation | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 31542297 | |
119 | Crotonylation | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 21925322 | |
119 | Other | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 27105115 | |
119 | Sumoylation | IQAVLLPKKTESHHK EEEEECCCCCHHHHH | 72.76 | 19608861 | |
120 | Glutarylation | QAVLLPKKTESHHKA EEEECCCCCHHHHHC | 56.43 | 31542297 | |
120 | Ubiquitination | QAVLLPKKTESHHKA EEEECCCCCHHHHHC | 56.43 | 16457589 | |
120 | Crotonylation | QAVLLPKKTESHHKA EEEECCCCCHHHHHC | 56.43 | 21925322 | |
120 | N6-crotonyl-L-lysine | QAVLLPKKTESHHKA EEEECCCCCHHHHHC | 56.43 | - | |
120 | Acetylation | QAVLLPKKTESHHKA EEEECCCCCHHHHHC | 56.43 | 164053 | |
120 | Sumoylation | QAVLLPKKTESHHKA EEEECCCCCHHHHHC | 56.43 | - | |
121 | Phosphorylation | AVLLPKKTESHHKAK EEECCCCCHHHHHCC | 49.17 | 25159151 | |
123 | Phosphorylation | LLPKKTESHHKAKGK ECCCCCHHHHHCCCC | 35.80 | 25159151 | |
126 | N6-crotonyl-L-lysine | KKTESHHKAKGK--- CCCHHHHHCCCC--- | 46.50 | - | |
126 | Ubiquitination | KKTESHHKAKGK--- CCCHHHHHCCCC--- | 46.50 | 23000965 | |
126 | Crotonylation | KKTESHHKAKGK--- CCCHHHHHCCCC--- | 46.50 | 21925322 | |
126 | Glutarylation | KKTESHHKAKGK--- CCCHHHHHCCCC--- | 46.50 | 31542297 | |
128 | Ubiquitination | TESHHKAKGK----- CHHHHHCCCC----- | 72.53 | 25015289 | |
130 | Ubiquitination | SHHKAKGK------- HHHHCCCC------- | 57.36 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
2 | S | Phosphorylation | Kinase | RPS6KA5 | O75582 | Uniprot |
121 | T | Phosphorylation | Kinase | DCAF1 | Q9Y4B6 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | BMI1 | P35226 | PMID:21772249 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF2 | Q99496 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | PRC1 | O43663 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | BMI1#RNF2 | P35226#Q99496 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
2 | S | Acetylation |
| 15010469 |
2 | S | Phosphorylation |
| 15010469 |
2 | S | Phosphorylation |
| 15010469 |
2 | S | Phosphorylation |
| 15010469 |
4 | R | Methylation |
| 15823041 |
14 | K | ubiquitylation |
| 22980979 |
14 | K | ubiquitylation |
| 22980979 |
16 | K | ubiquitylation |
| 22980979 |
16 | K | ubiquitylation |
| 22980979 |
27 | K | Methylation |
| 15386022 |
27 | K | ubiquitylation |
| 15386022 |
63 | K | ubiquitylation |
| 15386022 |
105 | Q | Methylation |
| 24352239 |
120 | K | ubiquitylation |
| 15386022 |
120 | K | ubiquitylation |
| 15386022 |
121 | T | Phosphorylation |
| 15078818 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of H2A2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PARP1_HUMAN | PARP1 | physical | 20525793 | |
DNJC2_HUMAN | DNAJC2 | physical | 21179169 | |
RING2_HUMAN | RNF2 | physical | 21179169 | |
BMI1_HUMAN | BMI1 | physical | 21179169 | |
HDAC1_HUMAN | HDAC1 | physical | 21179169 | |
A4_HUMAN | APP | physical | 21832049 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Precise characterization of human histones in the H2A gene family bytop down mass spectrometry."; Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.; J. Proteome Res. 5:248-253(2006). Cited for: MASS SPECTROMETRY, ACETYLATION AT SER-2 AND LYS-6, AND UBIQUITINATIONAT LYS-120. | |
"Deimination of histone H2A and H4 at arginine 3 in HL-60granulocytes."; Hagiwara T., Hidaka Y., Yamada M.; Biochemistry 44:5827-5834(2005). Cited for: ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND MASS SPECTROMETRY. | |
"Characterization of histones H2A and H2B variants and their post-translational modifications by mass spectrometry."; Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.; Mol. Cell. Proteomics 5:541-552(2006). Cited for: IDENTIFICATION BY MASS SPECTROMETRY, ACETYLATION AT LYS-6, ANDPHOSPHORYLATION AT SER-2. | |
Phosphorylation | |
Reference | PubMed |
"Characterization of histones H2A and H2B variants and their post-translational modifications by mass spectrometry."; Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.; Mol. Cell. Proteomics 5:541-552(2006). Cited for: IDENTIFICATION BY MASS SPECTROMETRY, ACETYLATION AT LYS-6, ANDPHOSPHORYLATION AT SER-2. | |
"Phosphorylation of histone H2A inhibits transcription on chromatintemplates."; Zhang Y., Griffin K., Mondal N., Parvin J.D.; J. Biol. Chem. 279:21866-21872(2004). Cited for: PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2. | |
Ubiquitylation | |
Reference | PubMed |
"Precise characterization of human histones in the H2A gene family bytop down mass spectrometry."; Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.; J. Proteome Res. 5:248-253(2006). Cited for: MASS SPECTROMETRY, ACETYLATION AT SER-2 AND LYS-6, AND UBIQUITINATIONAT LYS-120. | |
"DNA damage triggers nucleotide excision repair-dependentmonoubiquitylation of histone H2A."; Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M.,de Waard H., Wu J., Yuan L., Citterio E., Houtsmuller A.B.,Neefjes J., Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.; Genes Dev. 20:1343-1352(2006). Cited for: UBIQUITINATION AT LYS-120. | |
"Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox genesilencing."; Cao R., Tsukada Y., Zhang Y.; Mol. Cell 20:845-854(2005). Cited for: UBIQUITINATION AT LYS-120. | |
"Role of histone H2A ubiquitination in Polycomb silencing."; Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P.,Jones R.S., Zhang Y.; Nature 431:873-878(2004). Cited for: UBIQUITINATION AT LYS-120. |